Alendronate sodium is a drug which belongs to a medicine group called bisphosphonates. It contains alendronate monosodium salt and minimal amounts of starch, mannitol, magnesium stearate, microcrystalline cellulose, and sodium starch glycoate.
It was introduced in the market to treat osteoporosis in men and women. It goes by the name of Fosamax. It is also used to treat Paget’s disease and reduce bone mass. Side-effects of taking this drug includes heartburn, pain in legs & chest, and numbness.
The alendronate sodium market is projected to experience a significant growth rate during the forecast period (2015-2020). The high growth rate can be ascribed to the compound being a vital ingredient in many medicines.
The advent of other lifestyle-related diseases such as insomnia and rheumatoid arthritis will be a prime factor influencing market growth. Toxic nature of the drug can pose a challenge to industry growth.
Product types include freeze-dried powder and injections. Hospitals, clinics, and others constitute as major market applications. Hospitals will record a decent demand for the drug in the forecast period.
It has been recommended by doctors to treat osteoporosis and reduce bone resorption. The drug combined with nanoparticles is expected to improve bone regeneration. This could prove to be beneficial to the alendronate sodium industry.
Regions covered under the market are USA, UK, Japan, Australia, Germany, Switzerland, Singapore, Canada, and Italy. USA will lose market shares due to lethal side-effects of the drug causing discontent among patients. UK, Switzerland, and Germany will experience sluggish growth due to the tough market regulations.
Prominent manufacturers in the global alendronate sodium market are Xi'an Miracle Biotechnology Co., Ltd., Sigma-Aldrich, Cayman Chemical Company, and Merck Sharp & Dohme (MSD) Pty Ltd. The global market is competitive in nature. New participants can gain an entry to the market as drug patents of major pharmaceutical companies have reached their expiry dates.
To Read more reports of this category:
http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
Table of Contents:
Chapter One Introduction of Alendronate sodium Industry
1.1 Brief Introduction of Alendronate sodium
1.2 Development of Alendronate sodium Industry
1.3 Status of Alendronate sodium Industry
Chapter Two Manufacturing Technology of Alendronate sodium
2.1 Development of Alendronate sodium Manufacturing Technology
2.2 Analysis of Alendronate sodium Manufacturing Technology
2.3 Trends of Alendronate sodium Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Company A
3.2 Company B
3.3 Company C
3.4 Company D
3.5 Company E
3.6 Company F
3.7 Company G
3.8 Company H
Chapter Four 2010-2015 Global and Chinese Market of Alendronate sodium
4.1 2010-2015 Global Capacity, Production and Production Value of Alendronate sodium Industry
4.2 2010-2015 Global Cost and Profit of Alendronate sodium Industry
4.3 Market Comparison of Global and Chinese Alendronate sodium Industry
4.4 2010-2015 Global and Chinese Supply and Consumption of Alendronate sodium
4.5 2010-2015 Chinese Import and Export of Alendronate sodium
It was introduced in the market to treat osteoporosis in men and women. It goes by the name of Fosamax. It is also used to treat Paget’s disease and reduce bone mass. Side-effects of taking this drug includes heartburn, pain in legs & chest, and numbness.
The alendronate sodium market is projected to experience a significant growth rate during the forecast period (2015-2020). The high growth rate can be ascribed to the compound being a vital ingredient in many medicines.
The advent of other lifestyle-related diseases such as insomnia and rheumatoid arthritis will be a prime factor influencing market growth. Toxic nature of the drug can pose a challenge to industry growth.
Product types include freeze-dried powder and injections. Hospitals, clinics, and others constitute as major market applications. Hospitals will record a decent demand for the drug in the forecast period.
It has been recommended by doctors to treat osteoporosis and reduce bone resorption. The drug combined with nanoparticles is expected to improve bone regeneration. This could prove to be beneficial to the alendronate sodium industry.
Regions covered under the market are USA, UK, Japan, Australia, Germany, Switzerland, Singapore, Canada, and Italy. USA will lose market shares due to lethal side-effects of the drug causing discontent among patients. UK, Switzerland, and Germany will experience sluggish growth due to the tough market regulations.
Prominent manufacturers in the global alendronate sodium market are Xi'an Miracle Biotechnology Co., Ltd., Sigma-Aldrich, Cayman Chemical Company, and Merck Sharp & Dohme (MSD) Pty Ltd. The global market is competitive in nature. New participants can gain an entry to the market as drug patents of major pharmaceutical companies have reached their expiry dates.
To Read more reports of this category:
http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
Table of Contents:
Chapter One Introduction of Alendronate sodium Industry
1.1 Brief Introduction of Alendronate sodium
1.2 Development of Alendronate sodium Industry
1.3 Status of Alendronate sodium Industry
Chapter Two Manufacturing Technology of Alendronate sodium
2.1 Development of Alendronate sodium Manufacturing Technology
2.2 Analysis of Alendronate sodium Manufacturing Technology
2.3 Trends of Alendronate sodium Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Company A
3.2 Company B
3.3 Company C
3.4 Company D
3.5 Company E
3.6 Company F
3.7 Company G
3.8 Company H
Chapter Four 2010-2015 Global and Chinese Market of Alendronate sodium
4.1 2010-2015 Global Capacity, Production and Production Value of Alendronate sodium Industry
4.2 2010-2015 Global Cost and Profit of Alendronate sodium Industry
4.3 Market Comparison of Global and Chinese Alendronate sodium Industry
4.4 2010-2015 Global and Chinese Supply and Consumption of Alendronate sodium
4.5 2010-2015 Chinese Import and Export of Alendronate sodium
No comments:
Post a Comment